Benzodiazepines are among the most widely prescribed medications in the world, While benzodazepines are both clinically efficacious and safe, there are nonetheless concerns about whether inappropriate or over prescription of these drugs contributes to abuse and dependence. The site(s) and mechanism of behavioral actions of benzodiazepines in the central nervous system (CNS) remain uncertain. The proposed research is designed to test a working hypothesis that behaviors initiated by drug action at the benzodiazepine/y aminobutyric acidA (GABAA) receptor complex are mediated by a nitric oxide (NO)/cyclic GMP (cGMP)/protein kinase G (PKG) signaling pathway, i.e., stimulation of the benzodiazepine/GABAA receptor complex activates NO synthase (NOS) to produce NO, which activates soluble guanylyl cyclase (GC-S) to produce cGMP, which, in turn, activates a cyclic GMP-dependent protein kinase, leading to the behavioral effects. This will be accomplished by comparing the behavioral effects of the benzodiazepine chlordiazepoxide, the GABAA agonist 4,5,6,7-tetrahydro-isoxazolo[5,4-c]pyridin-3-ol (THIP) and nitrous oxide, another drug of abuse that appears to work at least in part through benzodiazepine/GABAA receptors, in mice following pharmacological manipulation of NOS, NO, guanylyl cyclase, cyclic GMP, and PKG in the CNS. Drug pretreatments will result in reduction in brain NO by inhibition of NOS, restoration of NO in NOS-inhibited brain, inhibition of NO action by an NO scavenger, reduction in brain cGMP by inhibition of GC-S, increase in brain cGMP by inhibition of cGMP degradation, and selective inhibition of protein kinase G (PKG). Other drug challenges will include NO-donors, dibutyryl cGMP and PKG-activators. Methods to be used in this research include behavioral testing in mice (elevated plus-maze and light/dark exploration), central microinjection of pretreatment drugs, and assays to measure cGMP and NOS or PKG enzyme activities. The purpose of the proposed studies is to identify the signaling pathway that mediates benzodiazepine-induced behaviors and provide a progressively more complete understanding, at the molecular level, of the pharmacological and neurochemical mechanisms underlying acute benzodiazepine-induced behaviors.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
1R01DA010343-01A1
Application #
2013564
Study Section
Human Development Research Subcommittee (NIDA)
Project Start
1997-01-15
Project End
1999-12-31
Budget Start
1997-01-15
Budget End
1997-12-31
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Illinois at Chicago
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
121911077
City
Chicago
State
IL
Country
United States
Zip Code
60612
Pruhs, Ronald J; Pena, Roehl T; Quock, Raymond M (2007) Antagonism of phosphoramidon-induced antinociception in mice by mu- but not kappa-opioid receptor blockers. Life Sci 80:1816-20
Emmanouil, Dimitris E; Papadopoulou-Daifoti, Z; Hagihara, Philip T et al. (2006) A study of the role of serotonin in the anxiolytic effect of nitrous oxide in rodents. Pharmacol Biochem Behav 84:313-20
Henry, Elisabeth Day; Ohgami, Yusuke; Li, Shuang et al. (2005) Correlation of inbred mouse sensitivity to nitrous oxide antinociception with brain nitric oxide synthase activity following exposure to nitrous oxide. Pharmacol Biochem Behav 81:764-8
Li, Shuang; Doss, Jason C; Hardee, Elizabeth J et al. (2005) Involvement of cyclic GMP-dependent protein kinase in nitrous oxide-induced anxiolytic-like behavior in the mouse light/dark exploration test. Brain Res 1038:113-7
Li, Shuang; Chung, Eunhee; Quock, Raymond M (2004) Role of cyclic GMP in nitrous-oxide-induced anxiolytic-like behavior in the mouse light-dark exploration test. Behav Neurosci 118:648-52
Li, Shuang; Bieber, Andrew J; Quock, Raymond M (2004) Antagonism of nitrous oxide antinociception in mice by antisense oligodeoxynucleotide directed against neuronal nitric oxide synthase enzyme. Behav Brain Res 152:361-3
Elfline, Geraldine S; Branda, Emily M; Babich, Michael et al. (2004) Antagonism by NOS inhibition of the behavioral effects of benzodiazepine and GABAA receptor agonists in the mouse elevated plus-maze. Neuropsychopharmacology 29:1419-25
Li, Shuang; Dai, Yang; Quock, Raymond M (2003) Antisense knockdown of neuronal nitric oxide synthase antagonizes nitrous oxide-induced behavior. Brain Res 968:167-70
Li, Shuang; Ohgami, Yusuke; Dai, Yang et al. (2003) Antagonism of nitrous oxide-induced anxiolytic-like behavior in the mouse light/dark exploration procedure by pharmacologic disruption of endogenous nitric oxide function. Psychopharmacology (Berl) 166:366-72
Li, Shuang; Quock, Raymond M (2002) Effects of a nitric oxide donor on behavior and interaction with nitrous oxide in the mouse light/dark exploration test. Eur J Pharmacol 447:75-8

Showing the most recent 10 out of 11 publications